NASDAQ: VTVT       Vtv Theraptcs Cl A
Last Price Today's Change   Day's Range   Trading Volume
2.12   -0.04 (1.85%)  2.01 - 2.181  181,839


Avg Volume (4 weeks):1,316,011
4 Weeks Range:1.82 - 2.33
4 Weeks Price Volatility (%):
52 Weeks Range:1.44 - 4.75
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

vTv Therapeutics Inc operates in the United States healthcare sector. Its key business includes the development of orally administered small molecule drug candidates for the treatment of neurological disorders such as the Alzheimer's disease. Its major drug candidate to treat Alzheimer's is azeliragon (TTP488), an orally administered drug. Its other products include TTP399, type II diabetes drug candidate. TTP399 is also an orally administered drug that targets the glucagon-like peptide-1 receptor. It also has over three additional programs in various stages of clinical development for the prevention of muscle weakness and the treatment of inflammatory disorders.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

1933  4294  421  3253 

Top 10 Active Counters
 NAKD 0.483+0.047 
 LK 1.38+1.38 
 ACST 0.881+0.124 
 BBIG 7.20+5.66 
 WPX 9.43+0.48 
 CLSN 2.04+0.765 
 F 11.867+1.007 
 CTRM 0.343+0.018 
 SNDL 0.662-0.018 
 ADTX 5.619+3.009